In CRC, miR-155 targets protein tyrosine phosphatase receptor J-type (PTPRJ) mRNA, inhibits the anti-proliferation effects of PTPRJ, promotes the proliferation and migration of tumor cells, and activates the AKT pathway (Zhang et al., 2017a). This evidence concerns the gene PTPRJ and colorectal carcinoma.